However, p21 was found to be downregulated by etomoxir in myeloma cells, suggesting that other cell cycle regulators might have mediated the anti-proliferative effect of etomoxir in myeloma cells [45]. This evidence concerns the gene CDKN1A and plasma cell myeloma.